Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.23
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.13 / +1.83%
Today’s Change
4.26
Today|||52-Week Range
11.15
-4.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$494.8M

Company Description

Progenics Pharmaceuticals, Inc. engages in developing medicines for oncology. It offers clinical trials of product candidates for prostate cancer, and resumed a pivotal trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in Tarrytown, NY.

Contact Information

Progenics Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591
P:(914) 789-2800
Investor Relations:

Employees

Shareholders

Mutual fund holders53.10%
Other institutional44.27%
Individual stakeholders15.25%

Top Executives

Mark Robert BakerPresident, Chief Executive Officer & Director
Angelo William LovalloCFO, Treasurer, Principal Accounting Officer & VP
Nitya G. RaySenior Vice President-Manufacturing
Vivien WongVice President-Product Development
James GarrisonHead-Business Development & Commercial Strategy